Laurus Labs Q1 FY27 Results (NSE: LAURUSLABS)

· Analysis by Alpha Inflection

Signal: Margin expansion

The read

5th straight quarter of margin expansion: consolidated EBITDA margin hit 29.4% (+500bps YoY) on a potent mix of input cost tailwind (raw material % of revenue fell 420bps to 38.8%) and operating leverage (employee costs +20.4% vs revenue +29.1%). PAT more than doubled YoY to ₹362 Cr, with EPS ₹6.81. The momentum is sustained across both standalone and group levels, with group outperforming on subsidiary contributions.

Laurus Labs Q1 FY27 key financials
MetricValueYoYQoQ
Revenue₹2,026.31 Cr29.1%11.9%
EBIT₹596.42 Cr39.6%
Net profit₹362.07 Cr124.5%
EPS₹6.81125.5%
EBIT margin29.4%

P&L walk

Revenue grew 29.1% YoY to ₹2,026 Cr, driven by volume/price mix. Gross margin expanded 625bps to 57.6% as raw material cost fell to 38.8% of revenue from 43.0% a year ago (input cost tailwind). EBITDA margin hit 29.4% (+500bps YoY) as employee costs grew only 20.4% vs revenue +29.1% (operating leverage). Finance costs dropped 18.0% YoY. PAT surged 124.5% YoY to ₹362 Cr, EPS ₹6.81 (+125.5% YoY).

Key positives

Key concerns

View original filing

Research and educational content only. Not investment advice.